Skip to content

Clinical trials

Recruiting Phase 1/2 Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 1/2 Status: Recruiting Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20211
20221
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines1
BeiGene1
Guangzhou Lupeng Pharmaceutical Company LTD.1
Mayo Clinic1
ModeX Therapeutics, An OPKO Health Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia5
Lymphoma, Follicular4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Mantle-Cell3
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Non-Hodgkin2
Dendritic Cell Sarcoma, Interdigitating1
Lymphoma1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.